Agenus Inc. (NASDAQ:AGEN) is one of the most undervalued penny stocks to buy right now. On February 19, Agenus presented new translational and clinical biomarker data from its Phase 1b C-800-01 trial, ...

Feb 15 (Reuters) - Peter Steinberger, the founder of OpenClaw, is joining OpenAI, and the open-source bot is becoming a foundation, OpenAI CEO Sam Altman said on Sunday. "Peter Steinberger is joining ...

In mid-2023, around the time Elon Musk rebranded Twitter as X but before he discontinued free academic access to the platform’s data, my colleagues and I looked for signs of social bot accounts ...

Scott Shambaugh woke up early Wednesday morning to learn that an artificial intelligence bot had written a blog post accusing him of hypocrisy and prejudice. The 1,100-word screed called the ...

Website owners are reporting a sharp spike in the number of bots visiting their platforms in recent months. While the bots’ function is unclear, experts say they could represent an attempt to scrape ...

From small publishers to US federal agencies, websites are reporting unusual spikes in automated traffic linked to IP addresses in Lanzhou, China. When he first noticed the traffic spike, Quintero ...

AstraZeneca is taking its oral GLP-1 drug into phase 3 on the back of a pair of midstage weight loss wins, despite remaining tight-lipped on how the candidate actually performed. The U.K.-based Big ...